Marianne Skov

Copenhagen Cystic Fibrosis Center, Rigshospitalet, Copenhagen, Denmark

Poster(s):

• (253) Change in liver biomarkers after introduction of elexacaftor/tezacaftor/ivacaftor: Results from a 12-month follow-up study in the national CF-cohort in Denmark
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (484) Change in pulmonary infections 12 months after elexacaftor/tezacaftor/ivacaftor introduction: Results from the Danish National Cystic Fibrosis Cohort
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET